Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a ...

The European Union does not have a clear strategy for managing candidate countries’ engagement with China, the European ...

One of the FDA’s potential approvals this month could break an existing monopoly in the treatment space for a rare growth ...

Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch for rare disease therapeutic MODEYSO® - ...

Black Friday 2025 is less than three weeks away, but with major retailers including Argos, Amazon and Currys dropping sales, ...

Securities.io maintains rigorous editorial standards and may receive compensation from reviewed links. We are not a ...

Exploring how mass and social media alike manufacture consent in the digital age, and what it means for the future of ...

Since the start of summer, the dolphin has delighted tourists but raised concerns among Venetians. Experts have mobilized to ...

Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch for rare disease therapeutic MODEYSO® - - Rare disease commercial ...